Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000589161 | SCV000698493 | pathogenic | Xeroderma pigmentosum | 2017-07-20 | criteria provided, single submitter | clinical testing | Variant summary: The c.566_567delAT (p.Tyr189Serfs) variant in XPC gene is a frameshift change predicted to cause loss of normal protein function through protein truncation or nonsense-mediated mRNA decay. These predictions were confirmed by Northern blot analysis that has revealed greatly reduced xeroderma pigmentosum complementation group C mRNA as well as reductions in post-ultraviolet survival rate, unscheduled DNA synthesis, global genome DNA repair deficiency and aborted plasmid host cell reactivation (Slor ,2000). The variant is present in the large control population dataset of ExAC at a low frequency 0.00004 (5/113986 chrs tested), exclusively in individuals of European descent (0.000079; 5/63374 chrs tested) which does not exceed the maximal expected frequency of a pathogenic allele (0.0014) in this gene. The variant of interest has been reported homozygously in at least 3 XP-C patients. The c.566_567delAT is cited as Pathogenic by reputable database/diagnostic center. Taken together, the variant was classified as Pathogenic. |
Counsyl | RCV000000282 | SCV000789545 | pathogenic | Xeroderma pigmentosum, group C | 2017-02-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001062453 | SCV001227254 | pathogenic | not provided | 2024-07-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr189Serfs*10) in the XPC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XPC are known to be pathogenic (PMID: 23173980, 25256075). This variant is present in population databases (rs752088918, gnomAD 0.06%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosum (PMID: 11121128). It has also been observed to segregate with disease in related individuals. This variant is also known as c.669_670delAT. ClinVar contains an entry for this variant (Variation ID: 258). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000000282 | SCV004206972 | pathogenic | Xeroderma pigmentosum, group C | 2024-03-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000000282 | SCV005656588 | pathogenic | Xeroderma pigmentosum, group C | 2024-03-30 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000000282 | SCV000020426 | pathogenic | Xeroderma pigmentosum, group C | 2000-12-01 | no assertion criteria provided | literature only |